Management

DR ARIEL BERESNIAK, MD, MPH, PhD

CHIEF EXECUTIVE OFFICER

Ariel Beresniak is an international expert in modelling and decision making in life sciences. He graduated as a physician with a 5 years specialization in Public Health from the Faculty of Medicine at University of Marseilles (France). Following his medical studies, he obtained his Master’s degree in Economic research and his PhD in Applied Mathematics in Economics at the Claude Bernard University in Lyon (France). Subsequently, he obtained two certificates in Healthcare Evaluation at the Harvard School of Public Health (USA), followed by an Accreditation to Supervise Research (France).


During the past 25 years, Ariel Beresniak has developed his expertise in both the academic and the industry world. He was formerly Head of Health Economics for Glaxo-Wellcome (1993-1999), and Global Head of Pharmacoeconomics for Serono-international (1999-2004).

Ariel Beresniak is the author and co-author of numerous articles within modelling and decision-making analyses. He also wrote several reference books in French, Spanish, Portuguese and Japanese on these same topics.

Founder and Chief Executive Officer of Data Mining International SA since 2004, Ariel Beresniak is also expert-consultant for the World Health Organization, the European commission and is accredited to supervise research (HDR) at Paris-Descartes University (France).

Scientific publications

DANIELLE DUPONT, PhD, MSc, BPharm

CHIEF SCIENTIFIC OFFICER

Danielle Dupont, B.Pharm., M.Sc., Ph.D., is Chief Scientific Officer at DMI. She holds a Bachelor Degree in Pharmacy, a Master in Sciences from the University of Montreal (Canada), and a Ph.D. in Health Economics from Claude Bernard Lyon I University (France). Danielle cumulates more than 5 years experience as Chief Scientific Officer at Data Mining International, and as General Manager of Data Mining America. Bringing 20 years of experience in leadership roles in the pharmaceutical industry in North America and in Europe, her main domains of expertise include health technology assessment, market access, pricing and reimbursement strategies, outcomes research, value demonstration, innovative business modelling, eHealth, medical and scientific affairs.


Danielle also cumulates 7 years of  clinical practice in hospitals and academic settings in Canada. Involved in multiple public/private research projects and international scientific consortia, Danielle collaborates with thought leaders from the international scientific community, towards enhancing value in health and other business sectors, across geographies. Danielle is leading various business modelling innovation strategies in eHealth, designing multi-stakeholders value chains, and conducting  evidence-based cost-benefit assessments and advanced simulation modelling towards assisting decision-making, and establishing best practices and sustainability.

Scientific publications

 

ALINA JUUSTI-HAWKES, MA

HEAD OF INTERNATIONAL BUSINESS DEVELOPMENT

Alina Juusti-Hawkes holds a Master of Arts degree from the University of Tampere (Finland) where her multi-disciplinary studies in International Politics, Psychology, Sociology and languages have contributed to her wide profile and allowed her to work in various domains, namely in the financial and the pharmaceutical sector. Alina is responsible for the development of international communication and public relation with key stakeholders in order to ensure the effective development and implementation of the international marketing and business strategy.